evoke trial semaglutide Oral Ozempic for earlier Alzheimer's? NOPE. "Efficacy and safety of oral 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials ..." "Interpretation: Novo Nordisk's Alzheimer's trial results

Wegovy pen, an FDA-approved GLP-1 injection for weight loss, now available with Hers with no insurance required

The first biosimilar formulation of a GLP-1 receptor agonist, liraglutide, has recently been marketed, at a lower acquisition cost than the original formulation, whilst oral semaglutide remains the only currently available GLP-1 receptor agonist that is administered orally

A Shreveport doctor's clear, evidence-based guide.

I broke down the key differences in an infographic

Muscle loss diagnoses also increased over time

We are developing a number of novel programs for the treatment of neurological and metabolic disorders.